Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
8,116
Price
$260.49
Total Value
$2.11M
Shares Held After
89,525
% of Holdings
8.3%
EXELIXIS, INC. (EXEL)
Aftab Dana — EVP, Research and Development
Shares
29,873
Price
$44.35
Total Value
$1.32M
Shares Held After
664,024
% of Holdings
4.3%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
590
Price
$69.82
Total Value
$41.19K
Shares Held After
105,212
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
212
Price
$68.54
Total Value
$14.53K
Shares Held After
105,802
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,629
Price
$69.82
Total Value
$113.74K
Shares Held After
106,014
% of Holdings
1.5%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
588
Price
$68.54
Total Value
$40.30K
Shares Held After
107,643
% of Holdings
0.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,030
Price
$153.38
Total Value
$157.98K
Shares Held After
301,185
% of Holdings
0.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,377
Price
$151.92
Total Value
$361.11K
Shares Held After
302,215
% of Holdings
0.8%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,413
Price
$151.12
Total Value
$515.77K
Shares Held After
304,592
% of Holdings
1.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,891
Price
$150.10
Total Value
$283.84K
Shares Held After
308,005
% of Holdings
0.6%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,988
Price
$149.17
Total Value
$296.55K
Shares Held After
309,896
% of Holdings
0.6%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
602
Price
$72.80
Total Value
$43.83K
Shares Held After
234,451
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,528
Price
$72.08
Total Value
$614.70K
Shares Held After
235,053
% of Holdings
3.5%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
18,923
Price
$71.03
Total Value
$1.34M
Shares Held After
243,581
% of Holdings
7.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
4
Price
$790.00
Total Value
$3.16K
Shares Held After
1,703
% of Holdings
0.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
56
Price
$785.61
Total Value
$43.99K
Shares Held After
1,707
% of Holdings
3.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
160
Price
$784.45
Total Value
$125.51K
Shares Held After
1,763
% of Holdings
8.3%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
220
Price
$783.29
Total Value
$172.32K
Shares Held After
1,923
% of Holdings
10.3%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
298
Price
$782.10
Total Value
$233.07K
Shares Held After
2,143
% of Holdings
12.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
209
Price
$781.28
Total Value
$163.29K
Shares Held After
2,441
% of Holdings
7.9%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
331
Price
$780.45
Total Value
$258.33K
Shares Held After
2,650
% of Holdings
11.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
208
Price
$779.55
Total Value
$162.15K
Shares Held After
2,981
% of Holdings
6.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
53
Price
$778.47
Total Value
$41.26K
Shares Held After
3,189
% of Holdings
1.6%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
50
Price
$775.50
Total Value
$38.77K
Shares Held After
3,242
% of Holdings
1.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
49
Price
$774.68
Total Value
$37.96K
Shares Held After
3,292
% of Holdings
1.5%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, R&D
Shares
18,668
Price
$100.91
Total Value
$1.88M
Shares Held After
234,800
% of Holdings
7.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
4,237
Price
$471.43
Total Value
$2.00M
Shares Held After
58,934
% of Holdings
6.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
11,712
Price
$470.54
Total Value
$5.51M
Shares Held After
63,171
% of Holdings
15.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
7,241
Price
$469.61
Total Value
$3.40M
Shares Held After
74,883
% of Holdings
8.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
19,662
Price
$468.57
Total Value
$9.21M
Shares Held After
82,124
% of Holdings
19.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
10,263
Price
$467.75
Total Value
$4.80M
Shares Held After
101,786
% of Holdings
9.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
1,848
Price
$465.80
Total Value
$860.80K
Shares Held After
112,049
% of Holdings
1.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
2,730
Price
$465.05
Total Value
$1.27M
Shares Held After
113,897
% of Holdings
2.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
920
Price
$463.91
Total Value
$426.80K
Shares Held After
116,627
% of Holdings
0.8%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
76,562
Price
$1.74
Total Value
$133.26K
Shares Held After
191,444
% of Holdings
28.6%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
109,375
Price
$1.78
Total Value
$194.84K
Shares Held After
191,444
% of Holdings
36.4%
ProMIS Neurosciences Inc. (PMN)
Kaplan Johanne — Chief Development Officer
Shares
1,629
Price
$15.35
Total Value
$25.01K
Shares Held After
3,941
% of Holdings
41.3%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
50,000
Price
$1.44
Total Value
$71.97K
Shares Held After
1,704,186
% of Holdings
2.9%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
4,422
Price
$17.57
Total Value
$77.69K
Shares Held After
15,080
% of Holdings
29.3%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
2,112
Price
$52.58
Total Value
$111.05K
Shares Held After
85,115
% of Holdings
2.4%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
6,967
Price
$52.58
Total Value
$366.32K
Shares Held After
226,106
% of Holdings
3.0%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
100
Price
$16.00
Total Value
$1.60K
Shares Held After
156,052
% of Holdings
0.1%
Keros Therapeutics, Inc. (KROS)
Seehra Jasbir — Director
Shares
7,015
Price
$16.17
Total Value
$113.43K
Shares Held After
385,708
% of Holdings
1.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
585
Price
$103.28
Total Value
$60.42K
Shares Held After
110,512
% of Holdings
0.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
800
Price
$102.10
Total Value
$81.68K
Shares Held After
111,097
% of Holdings
0.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,692
Price
$100.92
Total Value
$170.75K
Shares Held After
111,897
% of Holdings
1.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,308
Price
$100.27
Total Value
$131.15K
Shares Held After
113,589
% of Holdings
1.1%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.46
Total Value
$138.40K
Shares Held After
906,556
% of Holdings
4.2%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
100
Price
$69.38
Total Value
$6.94K
Shares Held After
45,157
% of Holdings
0.2%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
5,405
Price
$68.57
Total Value
$370.63K
Shares Held After
45,257
% of Holdings
10.7%
Showing 251–300 of 936 transactions (page 6 of 19)